Skip to main content
TipRanks
Go Ultimate75% OFF

Robert Rothermel Insider Profile

4 Followers

Robert Rothermel, former Director at DMK Pharmaceuticals, holds 133.50K shares in DMK Pharmaceuticals (Ticker: DMKPQ). Most recently, Robert Rothermel Bought 6,500 shares of DMK Pharmaceuticals on May 28, 2019 for an estimated value of $10.27K.

Robert Rothermel's Trading History

DMKPQ
DMK Pharmaceuticals
May 28, 2019―Informative Buy10.27K―
DMKPQ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 28, 2019Informative Buy$10.27K6,500$1.58-67.10%
May 27, 2016Uninformative Buy$0.00100,000$0.00―
Aug 17, 2015Informative Buy$23.23K7,000$3.31-27.30%
Sep 02, 2014Informative Buy$22.16K5,500$4.03-26.40%

You May Also Like

Robert Rothermel insider profile FAQ

What is the percentage of profitable transactions made by Robert Rothermel?
The percentage of profitable transactions made by Robert Rothermel is 0%.
What is the average return per transaction made by Robert Rothermel?
The average return per transaction made by Robert Rothermel is -40.20%.
What stocks does Robert Rothermel hold?
Robert Rothermel holds: DMKPQ stocks.
What was Robert Rothermel’s latest transaction?
Robert Rothermel’s latest transaction was an Informative Buy of $10.27K.
What was Robert Rothermel's most profitable transaction?
Robert Rothermel’s most profitable transaction was an Informative Buy of DMKPQ stock on September 2, 2014. The return on the trade was -26.40%.
What is Robert Rothermel's role in DMK Pharmaceuticals?
Robert Rothermel's role in DMK Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.